5/5/2025 - 10:21 AM EST - Parkland Corporation : And Sunoco LP announced today that the parties have entered into a definitive agreement whereby Sunoco will acquire all outstanding shares of Parkland in a cash and equity transaction valued at approximately $9.1 billion, including assumed debt. Parkland Corporation
shares T.PKI are trading up $2.89 at $39.17.
5/5/2025 - 9:56 AM EST - Microbix Biosystems Inc. : And commercialization partner, Sequel Pharma, LLC, has executed an agreement with a leading international contract development and manufacturing organization for production of the formulated and packaged drug of Kinlytic® urokinase, a biologic drug for dissolving blood clots. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.39.
5/5/2025 - 9:54 AM EST - Aritzia Inc. : Announced that the Toronto Stock Exchange has accepted its notice of intention to proceed with a normal course issuer bid. Aritzia Inc.
shares T.ATZ are trading down $0.19 at $56.23.
5/5/2025 - 9:50 AM EST - Colliers International : Announced today that its Colliers Engineering & Design division has acquired Terra Consulting Group, LLC, a specialty telecommunications infrastructure engineering firm based in Chicago, Illinois. This acquisition strengthens Colliers Engineering’s footprint in the Midwest and positions the platform to capitalize on the rapid growth in the telecommunications sector. Terms of the transaction were not disclosed. Colliers International
shares T.CIGI are trading up $0.01 at $168.19.
5/5/2025 - 9:44 AM EST - Aptose Biosciences Inc. : Reported updated and new data from Aptose’s Phase 1/2 TUSCANY trial in newly diagnosed acute myeloid leukemia (AML) patients dosed with a 40 mg or 80 mg dose of tuspetinib (TUS) in combination with standard of care dosing of venetoclax and azacitidine (TUS+VEN+AZA triplet). The TUS+VEN+AZA triplet is being developed as a safe and mutation agnostic frontline therapy to treat large, mutationally diverse populations of newly diagnosed AML patients who are ineligible to receive induction chemotherapy. Aptose Biosciences Inc.
shares T.APS are trading unchanged at $2.80.
5/5/2025 - 9:39 AM EST - Eupraxia Pharmaceuticals Inc. : Announced positive treatment outcomes from its ongoing RESOLVE Phase 1b/2a trial evaluating EP-104GI for the treatment of eosinophilic esophagitis. Most notably, nine-month data was disclosed for the first time demonstrating that all three patients dosed at 48mg of EP-104GI experienced sustained or improved treatment outcomes after nine months of therapy. Eupraxia Pharmaceuticals Inc.
shares T.EPRX are trading unchanged at $5.51.
5/5/2025 - 9:35 AM EST - Xanadu Mines Ltd : Refers to its announcement dated April 7in relation to the Extension of the Zijin Put Option and Exclusivity Arrangements with its major shareholder and Joint Venture Partner, Zijin Mining Group Co. Ltd. Xanadu Mines Ltd
shares T.XAM are trading unchanged at $0.05.
5/5/2025 - 9:30 AM EST - IsoEnergy Ltd. : Announced that its common shares have commenced trading today on the NYSE American LLC under the symbol "ISOU". The Common Shares continue to be listed on the Toronto Stock Exchange under the symbol "ISO". IsoEnergy Ltd.
shares T.ISO are trading unchanged at $8.90.
5/5/2025 - 9:28 AM EST - Skeena Resources Limited : Reports continued progress on the permitting timeline for its 100%-owned Eskay Creek Gold-Silver Project. The Company has filed the Joint Permit Application for the BC Mines Act and Environmental Management Act with the BC Major Mine Office (MMO) for joint review with the Tahltan Central Government. Uploading of the application started on April 22 and was completed on April 30, 2025. Skeena Resources Limited
T.SKE
shares T.SKE are trading unchanged at $15.52.
5/2/2025 - 10:36 AM EST - Imperial Oil : Reported estimated net income in the first quarter of $1,288 million, up from net income of $1,225 million in the fourth quarter of 2024, primarily driven by higher Downstream margin capture. Quarterly cash flows from operating activities were $1,527 million, compared to $1,789 million generated in the fourth quarter of 2024. Imperial Oil
shares T.IMO are trading up $1.08 at $94.88.
